129 related articles for article (PubMed ID: 6962421)
1. [Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].
Vu Van H; Guyotat D; Fière D; Adeleine P; Gentilhomme O; Treille D; Imbert C; Coiffier B; Bryon PA; Viala JJ
Nouv Presse Med; 1982 Dec; 11(49):3637-9. PubMed ID: 6962421
[TBL] [Abstract][Full Text] [Related]
2. Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results.
Fiere D; Doillon M; Martin C; Vu Van T; Revol L
Biomedicine; 1976 Dec; 25(9):318. PubMed ID: 1069595
[TBL] [Abstract][Full Text] [Related]
3. [Non-lymphoblastic acute leukaemia: maintenance therapy by trial of a combination of chemo- and immunotherapy (author's transl)].
Sébahoun G; Gastaut JA; Imbert-Xeridat C; Favre R; Carcassonne Y
Nouv Presse Med; 1979 Feb; 8(9):663-5. PubMed ID: 377219
[TBL] [Abstract][Full Text] [Related]
4. Long-term remission in acute lymphoid leukemia patients on maintenance chemoimmunotherapy.
Eremeev VS; Rumyantsev AG; Akimova GV; Osipov SG; Kislyak NS; Bergolz VM
Neoplasma; 1981; 28(2):219-21. PubMed ID: 6942239
[TBL] [Abstract][Full Text] [Related]
5. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
6. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
7. The role of immunotherapy in acute myelogenous leukemia.
Foon KA; Smalley RV; Riggs CW; Gale RP
Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818
[TBL] [Abstract][Full Text] [Related]
8. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
9. [Prolonged survival in 16 cases of acute myeloid leukemia [author's transl)].
Fiere D; Martin C; Vu Van H; Coiffier B; Felman P; Bryon PA; Gentilhomme O; Revol L
Nouv Presse Med; 1978 Mar; 7(11):899-902. PubMed ID: 273885
[TBL] [Abstract][Full Text] [Related]
10. Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.
Feldman EJ; Brandwein J; Stone R; Kalaycio M; Moore J; O'Connor J; Wedel N; Roboz GJ; Miller C; Chopra R; Jurcic JC; Brown R; Ehmann WC; Schulman P; Frankel SR; De Angelo D; Scheinberg D
J Clin Oncol; 2005 Jun; 23(18):4110-6. PubMed ID: 15961759
[TBL] [Abstract][Full Text] [Related]
11. [Use of chemotherapy and immunotherapy in the treatment of patients with acute myeloblastic leukemia (proceedings)].
Russell JA; Powles RL
Minerva Med; 1977 Oct; 68(51):3528-32. PubMed ID: 270618
[No Abstract] [Full Text] [Related]
12. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production].
Kardaszewicz E; Japa J
Acta Haematol Pol; 1975; 6(2):149-55. PubMed ID: 1057344
[TBL] [Abstract][Full Text] [Related]
13. Outcome in elderly acute myeloid leukaemia.
Osman H; Murray M; Egan E; O'Dwyer M
Ir Med J; 2008; 101(10):307-10. PubMed ID: 19205141
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
[TBL] [Abstract][Full Text] [Related]
15. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for acute myelogenous leukemia.
Powles RL; Lister TA; Crowther D; McElwain T; Alexander P; Fairley GH
Bibl Haematol; 1975; (40):737-49. PubMed ID: 1057948
[TBL] [Abstract][Full Text] [Related]
17. BCG therapy in acute non lymphoid leukaemias.
Vuvan H; Fiere D; Doillon M; Martin C; Coiffier B; Felman P; Bryon PA; Favre-Gilly J; Revol L
Scand J Haematol; 1978 Jul; 21(1):40-6. PubMed ID: 358371
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in acute leukemias. Possible applications in children.
Mahoney DH; Starling KA
Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of active immunotherapy of acute myeloid leukemia.
Mathé G; Musset M; Schwarzenberg L; Hayat M; de Vassal F; Amiel JL; Pouillart P; Misset JL
Biomedicine; 1975 Sep; 23(7):291-3. PubMed ID: 1066168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
